Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 3
2000 1
2002 1
2003 2
2004 3
2005 1
2006 1
2007 2
2009 1
2011 3
2014 2
2015 4
2016 5
2017 18
2018 17
2019 19
2020 18
2021 30
2022 29
2023 19
2024 19
2025 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Results by year

Filters applied: . Clear all
Page 1
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO).
Francolini G, Allegra AG, Detti B, Di Cataldo V, Caini S, Bruni A, Ingrosso G, D'Angelillo RM, Alitto AR, Augugliaro M, Triggiani L, Parisi S, Facchini G, Banini M, Simontacchi G, Desideri I, Meattini I, Valicenti RK, Livi L; ARTO Working Group members. Francolini G, et al. J Clin Oncol. 2023 Dec 20;41(36):5561-5568. doi: 10.1200/JCO.23.00985. Epub 2023 Sep 21. J Clin Oncol. 2023. PMID: 37733977 Clinical Trial.
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patients.
Francolini G, Porreca A, Facchini G, Santini D, Bruni A, Simoni N, Trovò M, Osti MF, Fornarini G, Sisani M, Di Cataldo V, Detti B, Garlatti P, Bertini N, Serni S, Minervini A, Livi L. Francolini G, et al. Med Oncol. 2023 Dec 29;41(1):39. doi: 10.1007/s12032-023-02268-3. Med Oncol. 2023. PMID: 38157111 Clinical Trial.
Biology-guided radiotherapy in metastatic prostate cancer: time to push the envelope?
Lancia A, Ingrosso G, Detti B, Festa E, Bonzano E, Linguanti F, Camilli F, Bertini N, La Mattina S, Orsatti C, Francolini G, Abenavoli EM, Livi L, Aristei C, de Jong D, Al Feghali KA, Siva S, Becherini C. Lancia A, et al. Among authors: francolini g. Front Oncol. 2024 Sep 9;14:1455428. doi: 10.3389/fonc.2024.1455428. eCollection 2024. Front Oncol. 2024. PMID: 39314633 Free PMC article. Review.
Italian guidelines for age range and test interval in breast cancer screening programmes: GRADE-ADOLOPMENT of the European guidelines.
Deandrea S, Mantellini P, Rossi PG, Vecchio R, Capobussi M, Rosselli Del Turco M, Pietribiasi F, Bucchi L, Senore C, Sardanelli F, Battisti F, Giordano L, Paci E, Parmelli E, Saguatti G, Zappa M; Italian mammography screening, diagnosis guidelines Technical/Scientific Committee, Panel, Reviewers. Deandrea S, et al. Radiol Med. 2024 Dec;129(12):1778-1789. doi: 10.1007/s11547-024-01900-0. Epub 2024 Oct 26. Radiol Med. 2024. PMID: 39460891
Choline PET/CT in recurrent prostate cancer.
Detti B, Carnevale MG, Lucidi S, Burchini L, Caini S, Orsatti C, Bertini N, Roghi M, di Cataldo V, Fondelli S, Ingrosso G, Francolini G, Scartoni D, Sardaro A, Pisani A, Scoccianti S, Aristei C, Livi L. Detti B, et al. Among authors: francolini g. Front Oncol. 2023 Mar 21;13:1079808. doi: 10.3389/fonc.2023.1079808. eCollection 2023. Front Oncol. 2023. PMID: 37025599 Free PMC article.
Current diagnostic and therapeutic options in de novo low-volume metastatic hormone-sensitive prostate cancer.
Ingrosso G, Lancia A, Bardoscia L, Becherini C, Bottero M, Bertini N, Cai T, Caini S, Caserta C, Doccioli C, Festa E, Francolini G, Giacomelli I, Paolieri F, Scartoni D, Pisani AR, Bellavita R, Livi L, Aristei C, Detti B. Ingrosso G, et al. Among authors: francolini g. Expert Rev Anticancer Ther. 2025 Jul;25(7):741-754. doi: 10.1080/14737140.2025.2509760. Epub 2025 May 21. Expert Rev Anticancer Ther. 2025. PMID: 40394918 Review.
187 results